NDC 53346-1365

DR. RECKEWEG R65 Psoriasin Combination Product

Berberis Aquifolium 4x, Hydrocotyle Asiatica 4x, Arsenicum Album 12x, Calcarea Carbonica 30x, Graphites 12x, Natrum Muriaticum 30x

DR. RECKEWEG R65 Psoriasin Combination Product is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Pharmazeutische Fabrik Dr. Reckeweg & Co. The primary component is Mahonia Aquifolium Whole; Centella Asiatica; Arsenic Trioxide; Oyster Shell Calcium Carbonate, Crude; Graphite; Sodium Chloride.

Product ID53346-1365_cabf7ad1-d5ce-43d6-a802-24e462b7379a
NDC53346-1365
Product TypeHuman Otc Drug
Proprietary NameDR. RECKEWEG R65 Psoriasin Combination Product
Generic NameBerberis Aquifolium 4x, Hydrocotyle Asiatica 4x, Arsenicum Album 12x, Calcarea Carbonica 30x, Graphites 12x, Natrum Muriaticum 30x
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date1986-06-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NamePHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Substance NameMAHONIA AQUIFOLIUM WHOLE; CENTELLA ASIATICA; ARSENIC TRIOXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; GRAPHITE; SODIUM CHLORIDE
Active Ingredient Strength4 [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 53346-1365-5

50 mL in 1 BOTTLE (53346-1365-5)
Marketing Start Date1986-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53346-1365-5 [53346136505]

DR. RECKEWEG R65 Psoriasin Combination Product LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1986-06-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
MAHONIA AQUIFOLIUM WHOLE4 [hp_X]/50mL

OpenFDA Data

SPL SET ID:ad07e6da-25dc-405b-915a-bf12b709cf01
Manufacturer
UNII
UPC Code
  • 0669330001240

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.